Cargando…
The Type 2 Asthma Mediator IL-13 Inhibits Severe Acute Respiratory Syndrome Coronavirus 2 Infection of Bronchial Epithelium
Asthma is associated with chronic changes in the airway epithelium, a key target of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Many epithelial changes, including goblet cell metaplasia, are driven by the type 2 cytokine IL-13, but the effects of IL-13 on SARS-CoV-2 infection are u...
Autores principales: | Bonser, Luke R., Eckalbar, Walter L., Rodriguez, Lauren, Shen, Jiangshan, Koh, Kyung Duk, Ghias, Khadija, Zlock, Lorna T., Christenson, Stephanie, Woodruff, Prescott G., Finkbeiner, Walter E., Erle, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990122/ https://www.ncbi.nlm.nih.gov/pubmed/34982656 http://dx.doi.org/10.1165/rcmb.2021-0364OC |
Ejemplares similares
-
The type 2 asthma mediator IL-13 inhibits SARS-CoV-2 infection of bronchial epithelium
por: Bonser, Luke R., et al.
Publicado: (2021) -
Genomic characterization and therapeutic utilization of IL-13-responsive sequences in asthma
por: Koh, Kyung Duk, et al.
Publicado: (2022) -
Epithelial miR-141 regulates IL-13–induced airway mucus production
por: Siddiqui, Sana, et al.
Publicado: (2021) -
Cultures of human tracheal gland cells of mucous or serous phenotype
por: Finkbeiner, Walter E., et al.
Publicado: (2009) -
Function of the Airway Epithelium in Asthma
por: Hallstrand, Teal S., et al.
Publicado: (2012)